Kalowski Lee
CFO and President
Kalowski Lee has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Oct 14, 2026.
On the most recent filing, Kalowski Lee is listed as CFO and President at Q32 Bio Inc. Inside the rolling window, Kalowski Lee reported no open-market purchases and 4 open-market sales totaling $126K in QTTB. The largest disclosed transaction in the window is a sale of 3,972 QTTB shares on Aug 25, 2026, worth $66K.
Companies traded
Other insiders at QTTB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$126K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kalowski Lee made?
Kalowski Lee has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Kalowski Lee trade?
Kalowski Lee has filed SEC Form 4 disclosures for 1 company, including QTTB.
When was Kalowski Lee's most recent SEC Form 4 filing?
Kalowski Lee's most recent SEC Form 4 filing on Tracefour is dated Oct 14, 2026.
What is Kalowski Lee's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kalowski Lee is listed as CFO and President.
What is Kalowski Lee's total buy and sell value in the current window?
Inside the rolling retention window, Kalowski Lee bought $0 and sold $126K based on SEC Form 4 filings.
What was Kalowski Lee's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,972 QTTB shares on 2026-08-25, worth $66K, per SEC Form 4 filings.